Multimeric
-
BiondVax Pharmaceuticals Completes Flu Vaccine Clinical Trial
BiondVax Pharmaceuticals, an Israeli biopharmaceutical company, has announced the success of the Phase I/II clinical trial of the company’s Multimeric-001 universal flu vaccine, in trials that were conducted at the Sourasky Medical Center in Tel Av…
Multimeric | 08 January 2010
